Rong Yang
Director/Board Member at NATURE'S SUNSHINE PRODUCTS, INC.
Net worth: 353 360 $ as of 2024-03-30
Profile
Rong Yang is currently the Chief Executive Officer at Fosun Pharma USA, Inc. and an Independent Director at Nature's Sunshine Products, Inc. Yang holds a Master's in Business Administration from Harvard University, an undergraduate degree from Beijing Foreign Studies University, and a graduate degree from Nankai University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-20 | 17,013 ( 0.09% ) | 353 360 $ | 2024-03-30 |
Rong Yang active positions
| Companies | Position | Start |
|---|---|---|
| NATURE'S SUNSHINE PRODUCTS, INC. | Director/Board Member | 2022-05-31 |
Fosun Pharma USA, Inc.
 Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Chief Executive Officer | 2021-12-31 |
Training of Rong Yang
| Harvard University | Masters Business Admin |
| Beijing Foreign Studies University | Undergraduate Degree |
| Nankai University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NATURE'S SUNSHINE PRODUCTS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Fosun Pharma USA, Inc.
Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Rong Yang